
JPMorgan analyst Tessa Romero lowered the firm’s price target on Xenon Pharmaceuticals (XENE) to $80 from $82 and keeps an Overweight rating on the shares. The firm updated the company’s
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| XENE | Xenon | 38.78 | -1.33 | -3.32% |
| Name | Price | % Change | |
|---|---|---|---|
| $38.78 | -3.32% |

JPMorgan analyst Tessa Romero lowered the firm’s price target on Xenon Pharmaceuticals (XENE) to $80 from $82 and keeps an Overweight rating on the shares. The firm updated the company’s

Xenon Pharmaceuticals (($XENE)) has held its Q3 earnings call. Read on for the main highlights of the call. Xenon Pharmaceuticals delivered a strongly positive earnings call, led by the FDA

“We’ve made significant progress advancing azetukalner with our recent NDA submission to the FDA for focal seizures and through ongoing scientific exchange opportunities. We continue to have great confidence in

J.P. Morgan analyst Tessa Romero has maintained their bullish stance on XENE stock, giving a Buy rating today. Tessa Romero’s rating is based on several factors, led by the anticipated

In a report released today, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Xenon, with a price target of $74.00. Douglas Tsao’s rating is based on azetukalner’s favorable

Xenon ( ($XENE) ) has issued an announcement. On November 9, 2026, Xenon reported third-quarter financial results for the period ended September 30 and provided a business update. In September

Xenon Pharmaceuticals (XENE) is scheduled to report 3rd quarter earnings on 11/09/2026, after the market closes. Regarding Q3 estimates, Wall Street analysts expect Xenon Pharmaceuticals to post earnings of -$1.13

Xenon ( ($XENE) ) has issued an update. Xenon Pharmaceuticals announced participation in four healthcare investor conferences during the fourth quarter of 2026, with fireside chats scheduled in Boston, New

Xenon ( ($XENE) ) has shared an update. Xenon Pharmaceuticals announced that it will release its third-quarter 2026 financial results and provide a business update on November 9 after U.S.

Xenon ( ($XENE) ) has shared an announcement. Xenon Pharmaceuticals reported positive Phase 1 results and new preclinical findings for its ion channel modulators XEN1701 and XEN1120, supporting their progression
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 17, 2026 | ||||
| buy | Reiterated | Nov 11, 2026 | ||||
| buy | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 9, 2026 | ||||
| buy | Reiterated | Nov 9, 2026 | ||||
| buy | Reiterated | Oct 29, 2026 | ||||
| buy | Reiterated | Sep 21, 2026 | ||||
| buy | Reiterated | Sep 18, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 4, 2027TBA | $3.86B | $-1.14 | $1.58M | -0.23 | -8.35 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.